Amgen Inc. (NASDAQ:AMGN) Announces The Purchase of Immunology Drug Otezla from Celgene Corporation (NASDAQ:CELG)
Amgen Inc. (NASDAQ:AMGN) has announced the purchase of Celgene Corporation’s (NASDAQ:CELG) leading immunology drug Otezla for around $13.4 billion. Otezla purchase deal to be finalized […]